136 related articles for article (PubMed ID: 6285061)
1. Circulating immune complex levels in patients with gestational trophoblastic neoplasia.
Rayner AA; Berkowitz R; Steele G; Schur PH; Rodrick ML; Goldstein DP; Harte PJ; Wilson RE; Zamcheck N; Munroe AE
J Natl Cancer Inst; 1982 Jul; 69(1):23-6. PubMed ID: 6285061
[TBL] [Abstract][Full Text] [Related]
2. Identification of material with paternal HLA antigen immunoreactivity from purported circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Berkowitz R; Rodrick ML; Ross DS; Goldstein DP; Zamcheck N; Wilson RE; Deasy JM
J Natl Cancer Inst; 1984 May; 72(5):983-90. PubMed ID: 6325794
[TBL] [Abstract][Full Text] [Related]
3. Circulating immune complex levels in patients with molar pregnancy.
Berkowitz RS; Lahey SJ; Rodrick ML; Rayner AA; Goldstein DP; Steele G
Obstet Gynecol; 1983 Feb; 61(2):165-8. PubMed ID: 6823357
[TBL] [Abstract][Full Text] [Related]
4. Characterization of antigenic components from circulating immune complexes in patients with gestational trophoblastic neoplasia.
Lahey SJ; Steele G; Rodrick ML; Berkowitz R; Goldstein DP; Ross DS; Ravikumar TS; Wilson RE; Byrn R; Thomas P
Cancer; 1984 Mar; 53(6):1316-21. PubMed ID: 6198067
[TBL] [Abstract][Full Text] [Related]
5. Measurement of CA-125 in trophoblastic disease.
Kohorn EI
Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
[TBL] [Abstract][Full Text] [Related]
6. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of macrophage colony-stimulating factor in trophoblastic disease.
Kohorn EI; Kacinski BM; Stanley ER
Gynecol Oncol; 2001 Mar; 80(3):383-6. PubMed ID: 11263936
[TBL] [Abstract][Full Text] [Related]
8. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Begent RH; Chester KA; Walker LC; Tucker DF
Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
[TBL] [Abstract][Full Text] [Related]
9. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
[TBL] [Abstract][Full Text] [Related]
10. Persistent trophoblast disease following partial molar pregnancy.
Wielsma S; Kerkmeijer L; Bekkers R; Pyman J; Tan J; Quinn M
Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
[TBL] [Abstract][Full Text] [Related]
11. Serum progesterone monitoring in post-molar surveillance.
Vasilev SA; Schlaerth JB; Ahn C; Sauer MV
Gynecol Oncol; 1994 Sep; 54(3):288-91. PubMed ID: 7522199
[TBL] [Abstract][Full Text] [Related]
12. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
[TBL] [Abstract][Full Text] [Related]
13. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
Tuncer ZS; Bernstein MR; Goldstein DP; Berkowitz RS
Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
[TBL] [Abstract][Full Text] [Related]
14. Treatment of trophoblastic neoplasia at the Cancer Control Agency of British Columbia.
Boyes DA; Pankratz E; Galliford B; White GM; Fairey RN; Yuen BH
Can Med Assoc J; 1977 Oct; 117(7):753-6. PubMed ID: 198082
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
[TBL] [Abstract][Full Text] [Related]
16. [Circulating immune complexes in breast cancer].
Abecassis J; Petit JC; Eber M; Klein T; Rodier D; Janser JC; Methlin G
Bull Cancer; 1985; 72(1):42-7. PubMed ID: 3872691
[TBL] [Abstract][Full Text] [Related]
17. Immunobiology of molar pregnancy and gestational trophoblastic tumors.
Berkowitz RS; Goldstein DP; Hoch EJ; Anderson DJ
J Reprod Med; 1984 Nov; 29(11):796-801. PubMed ID: 6097683
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy.
Feltmate CM; Growdon WB; Wolfberg AJ; Goldstein DP; Genest DR; Chinchilla ME; Lieberman ES; Berkowitz RS
J Reprod Med; 2006 Nov; 51(11):902-6. PubMed ID: 17165438
[TBL] [Abstract][Full Text] [Related]
19. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
Lavie I; Rao GG; Castrillon DH; Miller DS; Schorge JO
Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
[TBL] [Abstract][Full Text] [Related]
20. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy.
Wolfberg AJ; Berkowitz RS; Goldstein DP; Feltmate C; Lieberman E
Obstet Gynecol; 2005 Sep; 106(3):548-52. PubMed ID: 16135585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
